{"schema":"OTR-CURRENT-SIGNAL-READER-1","presentationSchema":"OTR-SIGNAL-SLIDES-1","signalId":"PDF-f17102e2351f5adf1802bf50-25","canonicalUrl":"https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/","title":"Existing scans become a starting point for new medicine research","category":"Technology","representation":"current-guided-reader","originalResearch":"preserved-separately","sources":[{"title":"www.nih.gov ↗","url":"https://www.nih.gov/news-events/news-releases/blood-pressure-drug-may-activate-health-promoting-brown-fat","contexts":["Source trail","What changed","Evidence, memory & review 3 linked sources"]},{"title":"www.nature.com ↗","url":"https://www.nature.com/articles/s41586-026-11162-7","contexts":["Source trail","What changed","Evidence, memory & review 3 linked sources"]},{"title":"arxiv.org ↗","url":"https://arxiv.org/abs/2603.08448","contexts":["Source trail","What changed","Evidence, memory & review 3 linked sources"]}],"chapters":[{"id":"otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-1","url":"https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-1","title":"OTR EMERGING DATA","topic":"emerging","kind":"cover","text":"Start with the main idea: what may be changing, how the clues connect, and what remains uncertain. We see a research pathway in which existing medical records guide laboratory experiments, rather than laboratory discoveries always coming first. NIH’s 14 October report describes AI-assisted analysis of brown fat in more than one hundred thousand cancer patients. Researchers then investigated losartan in cells and mice. The OTR data’s wider medical-AI discussion makes the connection clear: better extraction of information from old scans can create new questions to test. Brown fat uses energy to make heat. A pattern in patient records can suggest that a medicine or biological feature deserves closer study. It does not show that one caused the other. Laboratory work then tests a possible mechanism under controlled conditions. We infer that hospitals and research groups with well-governed imaging archives may find useful drug-repurposing leads without first creating an entirely new medicine. The critical next step remains human testing. Cancer-imaging patients are not a random sample of the public. Animal metabolism does not establish a treatment effect in people, and a familiar drug’s existing use does not make a new purpose proven. We make no recommendation to take or change medication. Within one week, we would look for the underlying protocol, independent scientific critique and plans for follow-up research. Longer-term confirmation would require a registered human study with an appropriate comparison group and clear safety monitoring. If the association disappears after accounting for patient differences, or the effect fails in people, the research opportunity would narrow substantially.","links":[]},{"id":"otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-2","url":"https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-2","title":"The idea, step by step","topic":"emerging","kind":"research","text":"Start with the main idea: what may be changing, how the clues connect, and what remains uncertain. Read the matching explanation in OTR EMERGING DATA .","links":["https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-1"]},{"id":"otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-3","url":"https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-3","title":"Research context","topic":"evidence","kind":"research","text":"Understand the background and earlier comparisons, including the differences that matter. Review status Evidence reviewed for this edition; proposed tests are pending, not completed outcomes. Six-agent edition: central explanation, contrary evidence, measurable test and schema reviewed. Coverage limits remain below. Publication and review times First published 15 Oct 2026, 09:32 SGT Research review due 22 October 2026, 08:31:20 SGT - operational research review, not proof that a longer-term outcome occurred. Horizon One-week evidence review; underlying engineering and clinical milestones can take much longer. Check time 22 October 2026, 08:31:20 SGT - operational research review, not proof that a longer-term outcome occurred. LEARNING REVIEWED WITH DISCLOSED LIMITS","links":[]},{"id":"otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-4","url":"https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-4","title":"The key clues","topic":"emerging","kind":"research","text":"See the main observations behind the idea, with their important qualifications. NIH primary release and linked Nature paper, compared with OTR Omega’s research-stage warning and AMIE workflow evidence.","links":[]},{"id":"otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-5","url":"https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-5","title":"What could change this view?","topic":"changes","kind":"research","text":"See what could change this interpretation and what still needs to be checked. Observational oncology cohort and mouse/cell experiments do not prove a useful human treatment.","links":[]},{"id":"otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-6","url":"https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-6","title":"What this means","topic":"emerging","kind":"research","text":"Read the takeaway and the limits that matter before drawing a conclusion. Check protocol and follow-up plans within one week; human efficacy requires later controlled studies. This is research and interpretation, not an investment price forecast. Source verification limits are listed below.","links":[]},{"id":"otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-7","url":"https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-7","title":"Evidence behind this view","topic":"evidence","kind":"research","text":"Review the information supporting this view and the limits on what it can show. Read the matching explanation in Chapter 4 .","links":["https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-4"]},{"id":"otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-8","url":"https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-8","title":"Evidence against this view","topic":"changes","kind":"research","text":"Check the opposing evidence and other explanations that could weaken this view. Read the matching explanation in Chapter 5 .","links":["https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-5"]},{"id":"otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-9","url":"https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-9","title":"How the research changed","topic":"evidence","kind":"research","text":"See what changed in the research and why, while keeping earlier recorded views separate. Learning review before publication The supplied direction was retained: No investible directional call. The supplied synthesis was retained. Reason: Owner explicitly requires complete source wording and every schema verbatim. Independent six-agent extraction and schema audit completed; source probabilities and clocks retained as attributed research. No new primary fact verification or probability recalibration claimed. No individual outcome lesson was cited in this review. This review belongs to the new draft before publication. Earlier published calls and their original deadlines remain unchanged. Not applicable: no investment direction or past contract is changed.","links":[]},{"id":"otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-10","url":"https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-10","title":"What people say vs the facts","topic":"evidence","kind":"research","text":"Compare what people say with the observations, without treating attention as proof. The full emerging-data passage distinguishes the reported capability from our testable inference. Announcement does not equal proven adoption.","links":[]},{"id":"otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-11","url":"https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-11","title":"Earlier research and limits","topic":"evidence","kind":"research","text":"Check what earlier forecast results are available and what they can tell us. Past results do not guarantee this outcome. No relevant resolved forecast cohort was reconstructed for this Technology claim; no hit-rate claim is made. No applied outcome lesson is claimed for this card.","links":[]},{"id":"otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-12","url":"https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-12","title":"Research reference","topic":"sources","kind":"research","text":"Check where the information came from, when it was observed and what was verified. OTR Database Data: OTR Omega Research Brief, 15 October 2026 04:02 SGT; Research Intelligence, 15 October 2026 03:58 SGT.","links":[]},{"id":"otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-13","url":"https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-13","title":"What’s changing?","topic":"evidence","kind":"research","text":"Follow the reasoning from the observations to the proposed result. A possible link is not proof. Read the matching explanation in OTR EMERGING DATA .","links":["https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-1"]},{"id":"otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-14","url":"https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-14","title":"The proposed development","topic":"evidence","kind":"research","text":"See how the stated chance was judged and where the estimate is uncertain. A percentage does not guarantee an outcome. The mechanism described above becomes clearer through the measurable review test; this remains an inference.","links":[]},{"id":"otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-15","url":"https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-15","title":"What remains unresolved","topic":"evidence","kind":"research","text":"Read the details behind this part of the research and how they connect to the main idea. No additional implementation evidence appears by the review; the original facts remain but the inference is unconfirmed.","links":[]},{"id":"otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-16","url":"https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-16","title":"How evidence can affect the estimate","topic":"evidence","kind":"research","text":"See how evidence can affect an estimate, including the starting assumptions. The new source adds a specific mechanism to the OTR data. Copies do not add independent confirmation; uncertainty remains.","links":[]},{"id":"otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-17","url":"https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-17","title":"How fair the comparisons are","topic":"evidence","kind":"research","text":"Check whether any earlier examples are comparable and whether the evidence overlaps. We keep laboratory results, supervised trials, company claims and broad deployment outcomes separate.","links":[]},{"id":"otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-18","url":"https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-18","title":"What to check","topic":"evidence","kind":"research","text":"Read the details behind this part of the research and how they connect to the main idea. Read the matching explanation in Chapter 4 and Chapter 5 .","links":["https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-4","https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-5"]},{"id":"otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-19","url":"https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-19","title":"Signal evolution · How this view developed","topic":"evidence","kind":"research","text":"See what changed in the research and why, while keeping earlier recorded views separate. Fresh synthesis for this issue; previous forecasts and outcomes remain unchanged.","links":[]},{"id":"otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-20","url":"https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-20","title":"What changed","topic":"evidence","kind":"research","text":"See what changed in the research and why, while keeping earlier recorded views separate. See What’s changing? above for the full evidence and explanation. Recorded public history We see a research pathway in which existing medical records guide laboratory experiments, rather than laboratory discoveries always coming first. NIH’s 14 October report describes AI-assisted analysis of brown fat in more than one hundred thousand cancer patients. Forecast prepared: 15 Oct, 09:00 SGT Published by OTR: 15 Oct 2026, 09:32 SGT","links":[]},{"id":"otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-21","url":"https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-21","title":"Why the view changed","topic":"evidence","kind":"research","text":"See what changed in the research and why, while keeping earlier recorded views separate. We connect the new technical mechanism with the evidence-quality and deployment limits recorded in the OTR data.","links":[]},{"id":"otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-22","url":"https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-22","title":"Evidence, memory & review","topic":"evidence","kind":"research","text":"Read the details behind this part of the research and how they connect to the main idea. We retain the opposing explanations rather than treating a future test as a completed result.","links":[]},{"id":"otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-23","url":"https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-23","title":"People and organisations","topic":"evidence","kind":"research","text":"Identify the people, organisations or assets discussed and the part they play in the research. NIH; Rockefeller University; Memorial Sloan Kettering researchers; losartan study team","links":[]},{"id":"otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-24","url":"https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-24","title":"OTR reasoning · Why we see this connection","topic":"evidence","kind":"research","text":"Follow the reasoning from the observations to the proposed result. A possible link is not proof. Read the full OnTheRice’s Emerging Data passage above for the step-by-step causal connection and affected users.","links":[]},{"id":"otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-25","url":"https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-25","title":"Counterpoint · Another possible explanation","topic":"evidence","kind":"research","text":"Check the opposing evidence and other explanations that could weaken this view. Read the matching explanation in Chapter 5 .","links":["https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-5"]},{"id":"otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-26","url":"https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-26","title":"Evidence, memory & review 3 linked sources","topic":"sources","kind":"research","text":"Check where the information came from, when it was observed and what was verified. Source trail This evidence panel does not assign a score or probability. Any forecast estimate is shown separately with its own source and limitations.","links":[]},{"id":"otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-27","url":"https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-27","title":"Keep exploring","topic":"connections","kind":"finish","text":"Choose how to follow this Signal or compare it with other research. Track this Signal to find it again, compare the evidence, and revisit its recorded outcome. Explore more Signals →","links":["https://ontherice.org/signals/"]},{"id":"otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-28","url":"https://ontherice.org/signals/PDF-f17102e2351f5adf1802bf50-25/#otr-slide-PDF-f17102e2351f5adf1802bf50-25-detail-28","title":"Terms in simple English","topic":"glossary","kind":"glossary","text":"Find plain meanings for the specialist terms used in this research. AI or machine learning Software learning patterns from examples to perform tasks. Its output can be wrong. UTC and SGT UTC is a world time standard. SGT is Singapore time, eight hours ahead of UTC. Repurposing testing an existing medicine for another use. Association two things occur together without proving cause.","links":[]}]}